Dalgleish, Raymond http://orcid.org/0000-0001-7667-187X
Micha, Dimitra http://orcid.org/0000-0001-7890-4411
Superti-Furga, Andrea http://orcid.org/0000-0002-3543-7531
van Dijk, Fleur S. http://orcid.org/0000-0001-6341-169X
Sillence, David O. http://orcid.org/0000-0002-5638-2998
Article History
Received: 16 October 2023
Accepted: 1 July 2024
First Online: 19 July 2024
Declarations
:
: There are no ethical or consent issues as no patient data are included in this article.
: Consent is not relevant as no patient data are included in this article.
: None of the authors have competing interests.
: RD has investigated the molecular genetic basis of osteogenesis imperfecta and Ehlers Danlos syndrome since the 1980s. He established variant databases for these two disorders in the 1990s: and .DM has studied connective tissue disorders including osteogenesis imperfecta for many years. She now maintains the osteogenesis imperfecta variant database with colleagues at Amsterdam UMC.AS-F is a clinical geneticist with specific interests in connective tissue disorders including osteogenesis imperfecta. He was corresponding author of both the 2010 and 2023 revisions of the nosology of genetic skeletal disorders.FSvD is a clinical geneticist who has investigated osteogenesis imperfecta and Ehlers Danlos syndrome from both the clinical and genetical perspectives. She currently works at the North West Thames Regional Genetics Service, London UK, specialising in osteogenesis imperfecta and monogenic forms of Ehlers Danos syndrome. She is also on the Medical Advisory board of care4brittle bones. She co-wrote an extensive review of OI types with DOS in 2014.DOS is a medical geneticist who established the first classification of osteogenesis imperfecta in 1979. He has contributed widely to revisions of skeletal disorder nosologies including the 2023 revision He currently serves on the International Nomenclature Committee for Constitutional Disorders of the Skeleton.